Interaction between endogenous circulating sulfated-glycosaminoglycans and plasma proteins.

[1]  D. Nordström,et al.  Plasma glycosaminoglycans in systemic lupus erythematosus. , 1987, The Journal of rheumatology.

[2]  M. Lyon,et al.  Structure and function of heparan sulphate proteoglycans. , 1986, The Biochemical journal.

[3]  D. Lane,et al.  Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4. , 1986, The Journal of biological chemistry.

[4]  I. Staprans,et al.  Isolation and characterization of glycosaminoglycans in human plasma. , 1985, The Journal of clinical investigation.

[5]  M. Ruggiero,et al.  Complexing of heparin with phosphatidylcholine. A possible supramolecular assembly of plasma heparin. , 1985, The Biochemical journal.

[6]  K. Nordling,et al.  Extension and structural variability of the antithrombin-binding sequence in heparin. , 1984, The Journal of biological chemistry.

[7]  H. Gralnick,et al.  Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder. , 1984, The New England journal of medicine.

[8]  H. Engelberg.  Heparin and the atherosclerotic process. , 1984, Pharmacological reviews.

[9]  Denis R. Miller,et al.  A heparin‐like anticoagulant in an 8‐month‐old boy with acute monoblastic leukemia , 1984, American journal of hematology.

[10]  D. Pepper,et al.  A sensitive competitive binding assay for exogenous and endogenous heparins. , 1982, Thrombosis research.

[11]  U. Lindahl,et al.  Attempted Determination of Endogenous Heparin in Blood , 1979, Thrombosis and Haemostasis.

[12]  M. Höök,et al.  Glycosaminoglycans and their binding to biological macromolecules. , 1978, Annual review of biochemistry.

[13]  A. Horwitz,et al.  Interrelated lipid alterations and their influence on the proliferation and fusion of cultured myogenic cells , 1978, The Journal of cell biology.

[14]  N. Di Ferrante,et al.  The glycosaminoglycans of human plasma. , 1969, The Journal of clinical investigation.